1. Progressive exercise and circulatory studies are reporteG on a selecteL group of patients with hypoxaemia and secondary polycythaemia before and after therapeutic decrease of packed cell volume.
polycythaemic patients (Chamberlain & Millard, 1963; Pengelly, 1966 Pengelly, , 1969 Gregory, 1971a; Harrison et al., 1971) , but previous studies have failed to demonstrate important objective improvement (Segel & Bishop, 1966) . In the present paper we report the results of progressive exercise tests and circulatory studies in a group of patients with lung disease and secondary polycythaemia before and after decrease in PCV following exchange transfusion with Dextran 40 (Gregory, 1971b) .
SUBJECTS A N D METHODS

Patients
Ten patients (Table 1) were studied, all of whom had a history of chronic bronchitis (Medical Research Council, 1965) with one or more acute exacerbations and at least one previous admission to hospital with oedema and elevated jugular venous pressure. In four patients (cases 1, 5, 6 and 9) there was radiological evidence of emphysema (Laws & Heard, 1962) and one had a paralysed right diaphragm; one patient had had a left upper lobectomy and thoracoplasty. The patients were selected for study because they all had a PCV of 55% or over. The purpose and nature of the investigations were fully explained to each patient; they were expressly told that the studies were not essential for diagnosis or treatment and all willingly agreed to participate. Eight of the patients were admitted primarily for treatment; two (cases 2 and 4) were admitted with acute infective exacerbations of their bronchitis and were studied after recovering fully from these. Each patient was observed in hospital for at least 1 week before the study began in order to avoid investigating them during an infective episode or when they presented evidence of heart failure; the weight of each patient measured daily remained constant during the week. Also during this week the patient was introduced to the laboratory, its staff and the exercise test.
Outline of the study
All patients were assessed by means of a progressive exercise test. At another sitting arterial blood was sampled at rest and during exercise at a steady work rate maintained for 6 min. Cardiac output and pulmonary artery pressure were measured in seven patients at rest and in five patients during exercise before and after treatment. One patient was studied only before treatment.
Procedure
On the first day a progressive exercise test was carried out using a hyperbolic cycle ergometer (Lanooy & Bonjer, 1956 ) fitted with an armchair instead of a saddle. The initial rate of work was 12.5 W which was sustained for 1 min; the work rate was then increased at minute intervals by 12.5 W until the patient was unable to continue. Heart rate and rhythm were monitored continuously using an ECG (electrocardiogram) with adhesive electrodes placed on the patient's back. In one patient (case 4) the exercise was terminated because of the appearance of ventricular extra-systoles. The progressive exercise test was repeated as soon as the cardiac and respiratory rates had returned to resting levels. On the same day total lung capacity and residual volume were estimated using the plethysmographic method (Dubois, Botelho & Comroe, 1956) and forced vital capacity and forced expiratory volume in 1 s were measured spirometrically.
On the second day, 2 h after a light breakfast, the patient returned to the laboratory and catheters were introduced percutaneously under local anaesthesia into the brachial artery of one arm and into a medial vein in the antecubital fossa of the other with the patient reclining comfortably on a couch. The venous catheter (Portex nylon 120 cm long and 0.75 mm internal diameter) was then advanced monitoring the venous pressure until a pulmonary arterial waveform was seen. Samples of pulmonary arterial blood could be withdrawn through this catheter in sufficient quantities for duplicate determinations of oxygen and carbon dioxide content (van Slyke manometric method) and blood gas tensions. The patient was then transferred to the chair of the ergometer where he rested for 15 min. Blood samples were then obtained from each catheter during two 3 min periods when expired air was being collected. Pulmonary artery pressure was also recorded. The patient then exercised for 6 min at a work rate chosen to be about 40% of the maximum rate achieved in the progressive exercise test and in the final 3 min expired air was again collected, systemic and pulmonary arterial blood samples obtained, and pulmonary artery pressure recorded. During the final minute of exercise an arterial blood sample was drawn for lactate and pyruvate estimations. RCM and plasma volume (PV) were measured on the same day.
On the following day blood was removed and replaced with an equal volume of Dextran 40 with the object of decreasing the PCV to between 45% and 50%.
At least 3 days later the progressive exercise and steady-state investigations were repeated on successive days. The progressive exercise test was carried out in duplicate in each patient as described above. Work rate during the 6 min steady-state exercise was identical to that used in the pretreatment study.
Technical methods
Haemoglobin was measured colorimetrically. PCV was measured with a microhaematocrit centrifuge. RCM and PV were measured simultaneously after an injection of the patient's own cells labelled with "Cr mixed with human serum albumin labelled with I2'I (Davies, 1971) . Lactate and pyruvate concentrations were estimated using a nicotinamide adenine dinucleotidelactate dehydrogenase system. The measurements were made spectrophotometrically (Unicam spectrophotometer SP 500).
Spirometry was performed using a water-sealed spirometer and lung volumes were measured in the body plethysmograph. Arterial blood oxygen and carbon dioxide tensions and pH were measured with appropriate electrodes (Instrumentation Laboratories 1 13), which were also used to analyse expired gas. Arterial and mixed venous oxygen contents were measured using the manometric method of van Slyke 8z Neil1 (1924) . The patient breathed through a lowresistance valve and expired air was collected in Douglas bags; the expired gas volume was measured using a dry gas meter. Oxygen consumption and carbon dioxide output were calculated from the volume and composition of the expired gas. Cardiac output was calculated by applying the direct Fick principle. Pulmonary artery pressure was measured using a strain gauge pressure transducer (Consolidated Electrodynamics type 4-326-L212) and recorded on a Helige multichannel recorder; calibrating signals were recorded before and after each investigation. Mean pulmonary artery pressure was obtained by electrical integration of the pulmonary artery pressure signal. The sternal angle was used as the reference point of pressure.
Normal values
Normal values for comparison with the haemodynamic data reported in this study were taken from results given by Granath, Jonsson & Strandell (1964) obtained from healthy men aged 61-83 years in whom measurements were made at rest and during exercise on a cycle ergometer in the sitting position. Granath et al. (1964) used the insertion of the fourth rib at the sternum as the zero reference for pulmonary artery pressure measurement.
RESULTS
All the patients had airflow obstruction and overinflated lungs ( Table 1) ; there were no important changes in lung volumes after treatment nor was there any change in the weight of any patient. The haematological results before and after exchange transfusion are given in Table 2 . There was little change in PV and the fall in whole blood volume was related to the therapeutic decrease of RCM.
The results of the progressive exercise tests are recorded in Table 3 and Fig. 1 . The work performed is expressed in joules in order to include not only the rate of work achieved but also the length of time the patient was able to exercise (1 W = 1 J/s). These exercise studies were repeated in all patients except one (case 4). The reproducibility of this rather crude assessment of exercise tolerance was remarkable considering the age and disability of the patients. Each of these eight patients was exhorted during the assessment to pedal to the point of exhaustion; it was found that the mean difference between the total work performed in the first and second exercise in sixteen duplicated studies was only 950 J (range 0-3189 J). The patients are divided into two groups (Table 3) on the basis of their own opinion of the change in their symptoms after treatment. In Group 1 were seven patients (cases 1-4 and 7-9) who claimed important symptomatic improvement. In five of these there was a marked increase in work done during the progressive exercise, in one there was an insignificant increase and in one there was no change. Five of these patients had had more than one exchange transfusion at intervals varying between 1 month and 1 year. Each time an increasing PCV was associated with symptomatic deterioration and each time symptoms were relieved after decrease of the PCV. Taken as a group the measured increase in exercise carried out on the cycle ergometer was significant (t = 3.07; P< 0.05). Group 2 contains two patients not benefited by the treatment.
One (case 5) noticed no important change in symptoms but he could do less work after exchange transfusion, and the other (case 6) said he felt worse after treatment and he too worked less after exchange transfusion; he had the lowest PCV before treatment and after treatment his PCV was only 40% which we would regard as lower than normal.
The results of the studies at rest and during steady work are given in Tables 4-7 . Systemic oxygen transport is the volume of oxygen contained in the blood ejected from the left ventricle/min calculated from cardiac ouput in litres/min and arterial oxygen content in ml/litre. Resting studies (Tables 4 and 5) All patients were hypoxic and hypercapnic except one who hyperventilated whenever he breathed through a mouthpiece. Arterial pH was low in four cases before treatment and rose to normal in one case after treatment. There were no significant changes in the mean values of arterial gas tensions or pH in this group of patients after decrease of PCV.
Cardiac output (Table 5 and Fig. 2 ) and stroke volume (Table 5 ) at rest were normal and there were no significant changes in these values after treatment. A slight fall in the mean value of systemic oxygen transport after treatment was caused by a fall in arterial oxygen content.
Mean pulmonary artery pressure was elevated at rest before treatment (Fig. 3 ) and fell markedly in one patient but was little changed in the other.
The relationship between carbon dioxide output and minute ventilation before and after treatment was normal.
Arterial lactate concentrations were normal in all patients before treatment and the mean value for the group was unchanged after treatment although the level in case 7 was elevated.
In summary, at rest there appeared to be no important objective changes after treatment. Exercise studies (Tables 6 and 7) The arterial blood results in one patient (case 6) are incomplete because he was unable to exercise for longer than 3 min after treatment. In case 1 during the pretreatment exercise study the right heart catheter passed back into the right ventricle and mean pulmonary artery pressure was therefore not obtained during this study.
During exercise arterial Po, (Pa, 02) and pH fell and arterial Pco, (Pa,co,) rose. There were no significant changes in arterial blood gas tensions and pH after treatment.
The increases of cardiac output and stroke volume on exercise before treatment were normal ( Table 5 and Fig. 2) . After treatment cardiac output on exercise was higher in four of the five patients than before treatment and this reflected a lower arteriovenous oxygen difference in each patient and an increase in oxygen consumption in three patients. The increase in cardiac output was almost entirely a result of an increase in stroke volume. There was no change in systemic oxygen transport after treatment.
Mean pulmonary artery pressure rose on exercise before and after treatment. Not only were the pressures abnormally raised but the rate of increase in pressure with increase in cardiac output was also abnormally steep (Fig. 3) . This was more obvious in the patients before treatment than after. Fig. 3 also demonstrates that at any given cardiac output the mean pulmonary artery pressure was lower after treatment than before.
The relationship between carbon dioxide output and minute ventilation on exercise before and after treatment was normal in all except one patient in whom it was slightly increased after treatment.
Arterial lactate concentration in the final minute of exercise rose significantly from the resting level. There were no obvious trends in the changes during exercise in either blood lactate concentration (Table 6 ) or lactatelpyruvate ratio before and after treatment. In summary, on exercise after treatment cardiac output was higher than before treatment with an increased mean oxygen consumption and a fall in mean arteriovenous oxygen difference. Systemic oxygen transport was unchanged. Mean pulmonary artery pressure was little changed on exercise except in one patient in whom it fell. There were no significant changes in mean arterial lactate or lactatelpyruvate ratios after treatment.
D I S C U S S I O N
One of the symptomatic improvements noted by patients with marked secondary polycythaemia after therapeutic decrease in PCV is an increase in exercise tolerance. Although pedalling exercise was unnatural for all the patients in this study, the exercise test was designed to be as simple as possible: only the electrocardiograph was monitored and the patient was not encumbered with a mouthpiece or nose clip. Each patient was familiarized with the cycle and, except in one, the progressive exercise assessment was repeated on each occasion before and after treatment. This test may at first sight be regarded as crude and insensitive in such a group of severely disabled patients. However, the reproducibility of the work performed on any one day was good and the changes observed in five of the patients who claimed subjective improvement after treatment were impressive ( Table 3 ). It is interesting that patients 5 and 6 who were not subjectively improved by treatment, performed less exercise after treatment. The significant overall improvement in the work capacity of the patients in Group 1 is comparable to that observed in patients with advanced chronic lung disease given oxygen-enriched air to breathe (Cotes & Gilson, 1956 ). However, the improvement they noted with oxygen was seen when the patient was unaware of what oxygen mixture he was breathing. Exchange transfusion, on the other hand, is an impressive procedure and perhaps the subjective improvement claimed by our patients could have been a placebo-like effect. Against this is the observation that patients' symptoms including cases 2,3,4, 8 and 9 of the present series, became worse as their PCV rose and were improved after every exchange transfusion which suggests that the treatment was not acting solely as a placebo. Nevertheless if a patient feels subjectively more alert and vital it is quite possible that he would perform more exercise than when he was feeling lethargic and muzzy. To this extent the changes in work capacity may be influenced by psychological factors incapable of direct measurement. This was one reason for studying the circulatory changes. Another point of some interest emerges from inspection of the oxygen consumption of all the patients during exercise. As a rough landmark a normal oxygen uptake of 1 litre/min at a work load of 50 W may be compared with these data. One of our patients consumed 0.83 litre/min when his work load was only 5 W; five other patients also behaved in this way but to a lesser extent. The obvious explanation for this would be that the work of breathing was greatly increased during the hyperventilation of exercise. Permutt (1971) ascribed a similar rise in oxygen consumption after giving histamine to an asthmatic patient to the fact that when airways obstruction was exaggerated by the drug, lung volume increased and then breathing took place on a part of the pressure-volume curve where the compliance of the lung was least; this means that inspiratory work was high and according to Permutt (1971) this accounted for the increase in oxygen requirement. In the present cases a similar explanation could be applied; during exercise hyperventilation could be accompanied by an increase in lung volume in patients with severe airways obstruction producing a similar state of pulmonary mechanical disadvantage to that described by Permutt (197 1). In the particular case cited pulmonary ventilation rose from 10 litres/min at rest to 27 litres/min during the exercise period at breathing frequencies of 20 breaths/min in each case. His resting oxygen consumption was 0.25 litre/min; if we add to this a further 0.20 litre/min for the exercise work, we are left with an excess oxygen uptake during exercise of about 0.4 litre/min. Values for the oxygen cost of breathing in patients of this kind, estimated by Levinson & Cherniack (1957) , are not far from this value. One other possibility, which cannot be ignored, nor can it be readily assessed, is that these patients coped with the ergometer inefficiently so that their metabolic work was much higher than the work done against the measured load; by no stretch of imagination could these patients be classed as trained.
A high PCV which impairs circulation might be expected to lead first to an increased pressure drop across a capillary bed and secondly to evidence of decreased tissue perfusion. In dogs in which PCV was changed acutely, increases in PCV were associated with an exponential increase in pressure drop across both the hind-limb capillary bed (Levy & Share, 1953) and the pulmonary capillary bed (Argarwal, Paltoo & Palmer, 1970) . Other workers (Replogle & Merrill, 1970) have shown that acute increases in PCV in anaesthetized dogs were associated with a fall in oxygen consumption and a rise in lactate/pyruvate ratio which suggested that there was both a decrease in aerobic and an increase in anaerobic metabolism.
In the patients in whom it was measured, pulmonary artery pressure was raised at rest and rose abnormally on exercise (Fig. 3) . Cardiac output was higher on exercise after treatment despite the fall in whole blood volume (Table 1) which of itself would tend to cause a fall in cardiac output. At this higher cardiac output mean pulmonary artery pressure was little changed indicating a decrease in pulmonary vascular resistance in spite of the more constricted pulmonary vascular bed resulting from the decreased circulating blood volume (Segel & Bishop, 1966) . This is most probably explained by a change in the flow properties of the blood.
In the present series there were no important changes in oxygen consumption or arterial lactate levels at rest. Exercise at identical work rates before and after decrease in PCV was associated with increases in oxygen consumption in five of the six patients who felt better after treatment but there were no consistent changes in arterial lactate concentrations. There is recent evidence that arterial lactate concentrations may be a poor reflection of muscle hypoxia (Karlson, 1971) but in studies in normal men breathing air and hypoxic gas mixtures (Naimark, Jones & Lal, 1965) and in patients with chronic lung disease breathing air and 30% oxygen (King, Cooke, Leitch & Flenley, 1973) arterial lactate levels were higher in the more hypoxic situation. We conclude that there is no evidence, from the relatively crude criterion of arterial blood lactate concentration, of any change in anaerobic metabolism associated with decrease in PCV. The higher oxygen consumption during exercise after treatment may mirror a true increase in aerobic tissue metabolism. Similar changes were observed by both Naimark et al. (1965) and King et al. (1973) in the studies already referred to. The systemic oxygen transport on exercise was not substantially affected by the treatment and the increase in oxygen consumption suggests that oxygen extraction by the tissues was increased. Segel & Bishop (1966 . 1967 found evidence for an increase in the dimensions of the peripheral pulmonary and systemic vasculature associated with the elevated total blood volume in both primary and secondary polycythaemia. It is possible therefore that the polycythaemic state is associated with dilatation of arteriovenous shunts and diversion of at least part of the RCM from capillary beds. Segel & Bishop (1966 , 1967 found no evidence of increased oxygen consumption after decrease in PCV in either primary or secondary polycythaemia but the design of their exercise study specifically excludes detection of such changes because they adjusted the post-treatment exercise level to produce as nearly similar oxygen consumption to the first as possible.
In conclusion this study has demonstrated that the subjective symptomatic benefit after therapeutic decrease in PCV in this group of patients is associated with a significant increase in work performed during progressive exercise on a cycle ergometer. The circulatory data suggest that the pulmonary vascular resistance is decreased. No clear-cut evidence for an increase in aerobic and a decrease in anaerobic metabolism associated with PCV decrease emerged from this study. There were no important changes in arterial lactate or lactate/pyruvate ratio at rest or on exercise which would provide a crude indicator of changes in anaerobic metabolism.
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